Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12637)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 18, 2015 (publication date) through Apr 15, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015; 7(11): 1450-1459 [PMID: 26085906 DOI: 10.4254/wjh.v7.i11.1450] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i11/1450.htm |
| Number | Citing Articles |
| 1 |
Somayyeh Asghari, Maryam Rafraf, Laleh Farzin, Mohammad Asghari-Jafarabadi, Seyed-Mostafa Ghavami, Mohammad-Hossein Somi. Effects of Pharmacologic Dose of Resveratrol Supplementation on Oxidative/Antioxidative Status Biomarkers in Nonalcoholic Fatty Liver Disease Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. Advanced Pharmaceutical Bulletin 2018; 8(2): 307 doi: 10.15171/apb.2018.036
|
| 2 |
You-Shan Tsai, Shih-Wei Lin, Yen-Lien Chen, Chin-Chu Chen. Effect of probioticsLactobacillus paracaseiGKS6,L. plantarumGKM3, andL. rhamnosusGKLC1 on alleviating alcohol-induced alcoholic liver disease in a mouse model. Nutrition Research and Practice 2020; 14(4): 299 doi: 10.4162/nrp.2020.14.4.299
|
| 3 |
Xupeng Bai, Weipeng Hong, Peiheng Cai, Yibei Chen, Chuncao Xu, Di Cao, Weibang Yu, Zhongxiang Zhao, Min Huang, Jing Jin. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicology and Applied Pharmacology 2017; 324: 12 doi: 10.1016/j.taap.2017.03.022
|
| 4 |
Mabel Graffigna, Natalia Catoira, Jimena Soutelo, Andreína Azpelicueta, Gabriela Berg, Cecilia Perel, Marta Elena Migliano, Marcela Aranguren, Carla Musso, Javier Farias. Diagnóstico de esteatosis hepática por métodos clínicos, bioquímicos y por imágenes. Revista Argentina de Endocrinología y Metabolismo 2017; 54(1): 37 doi: 10.1016/j.raem.2016.12.001
|
| 5 |
Yi Zhang, Hong An, Si-Yuan Pan, Dan-Dan Zhao, Jia-Cheng Zuo, Xiao-Ke Li, Ya Gao, Qian-Qian Mu, Na Yu, Yue Ma, Fang-Fang Mo, Si-Hua Gao. Jiang Tang Xiao Ke Granule, a Classic Chinese Herbal Formula, Improves the Effect of Metformin on Lipid and Glucose Metabolism in Diabetic Mice. Evidence-Based Complementary and Alternative Medicine 2016; 2016: 1 doi: 10.1155/2016/1592731
|
| 6 |
Heibatullah Kalantari, Mohammad Javad Khodayar, Najmaldin Saki, Layasadat Khorsandi, Ali Teymoori, Hadis Alidadi, Azin Samimi. Microarray analysis of apoptosis gene expression in liver injury induced by chronic exposure to arsenic and high-fat diet in male mice. Environmental Science and Pollution Research 2019; 26(25): 26351 doi: 10.1007/s11356-019-05907-3
|
| 7 |
M. Hossein Bagheri, A. Azamian-Jazi, E. Banitalebi, F. Kazeminasab, M. Hossein Nasr-Esfahani. Both high-intensity interval training and low-intensity endurance training decrease intrahepatic lipid deposits via alterations of the expression of HIF-1α, HIG2 in a murine model of non alcoholic fatty liver disease (NAFLD). Science & Sports 2021; 36(2): 120 doi: 10.1016/j.scispo.2020.01.006
|
| 8 |
Rohit Loomba, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C. Gordon. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Alimentary Pharmacology & Therapeutics 2020; 51(11): 1149 doi: 10.1111/apt.15679
|
| 9 |
Yuneivy Cepero-Donates, Grégory Lacraz, Farnaz Ghobadi, Volatiana Rakotoarivelo, Sakina Orkhis, Marian Mayhue, Yi-Guang Chen, Marek Rola-Pleszczynski, Alfredo Menendez, Subburaj Ilangumaran, Sheela Ramanathan. Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease. Cytokine 2016; 82: 102 doi: 10.1016/j.cyto.2016.01.020
|
| 10 |
Yun Shi, Jason Pizzini, Hanzhou Wang, Falguni Das, Parveez Ahamed Abdul Azees, Goutam Ghosh Choudhury, Jeffrey L. Barnes, Mengwei Zang, Susan T. Weintraub, Chih-Ko Yeh, Michael S. Katz, Amrita Kamat. β2-Adrenergic receptor agonist induced hepatic steatosis in mice: modeling nonalcoholic fatty liver disease in hyperadrenergic states. American Journal of Physiology-Endocrinology and Metabolism 2021; 321(1): E90 doi: 10.1152/ajpendo.00651.2020
|
| 11 |
Victoria Sid, Yue Shang, Yaw L. Siow, Susara Madduma Hewage, James D. House, Karmin O. Folic Acid Supplementation Attenuates Chronic Hepatic Inflammation in High‐Fat Diet Fed Mice. Lipids 2018; 53(7): 709 doi: 10.1002/lipd.12084
|
| 12 |
|
| 13 |
Rong Xie, Shaodong Chen, Fang Li, Liu Yang, Bangliang Yu. Pirfenidone attenuates nonalcoholic fatty liver disease through activation of the nuclear factor erythroid 2‐related factor 2 (Nrf2) signaling pathway. Journal of Biochemical and Molecular Toxicology 2023; 37(2) doi: 10.1002/jbt.23251
|
| 14 |
Ángela Rojas, Paloma Gallego, Antonio Gil-Gómez, Rocío Muñoz-Hernández, Lourdes Rojas, Rosario Maldonado, Rocío Gallego-Durán, Marta García-Valdecasas, José A. Del Campo, Juan D. Bautista, Manuel Romero-Gómez. Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype. Annals of Hepatology 2018; 17(2): 242 doi: 10.5604/01.3001.0010.8642
|
| 15 |
Lea Ladegaard Grønkjær, Charlotte Wernberg, Mette Munk Lauridsen. Non-alcoholic fatty liver disease: the role of the nurse. Gastrointestinal Nursing 2020; 18(Sup6): S15 doi: 10.12968/gasn.2020.18.Sup6.S15
|
| 16 |
Mohammad Reza Ghadir, Seyed Saeed Sarkeshikian, Ahmad Hormati, Faezeh Alemi, Pezhman Alavinejad, Maryam Jameshorani, Mansoureh Molaei, Mahdi Jahangiry. Efficacy of Atorvastatin Plus Aspirin in Comparison with Atorvastatin Alone on Liver Function and Degree of Fibrosis in Patients with Cryptogenic Cirrhosis: A Randomized Double-Blind Clinical Trial. Hepatitis Monthly 2019; 19(11) doi: 10.5812/hepatmon.92342
|
| 17 |
Yoosoo Chang, Jin-Won Noh, Joo Young Cheon, Yejin Kim, Young Dae Kwon, Seungho Ryu. Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60823-8
|
| 18 |
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
|
| 19 |
Kathryn Smedlund, Prabhatachandra Dube, Guillermo Vazquez. Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosis. Physiological Genomics 2016; 48(8): 644 doi: 10.1152/physiolgenomics.00067.2016
|
| 20 |
Tarana Arman, Katherine D. Lynch, Michelle L. Montonye, Michael Goedken, John D. Clarke. Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in Rats. Toxins 2019; 11(7): 398 doi: 10.3390/toxins11070398
|
| 21 |
Charlotte Brøns, Louise Justesen. The Human Gut-Liver-Axis in Health and Disease. 2019; : 65 doi: 10.1007/978-3-319-98890-0_4
|
| 22 |
Jian-Lin Lai, Yuan-E Lian, Jun-Yi Wu, Yao-Dong Wang, Yan-Nan Bai. Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice. Adipocyte 2021; 10(1): 532 doi: 10.1080/21623945.2021.1983241
|
| 23 |
Rohit A. Sinha, Brijesh K. Singh, Paul M. Yen. Direct effects of thyroid hormones on hepatic lipid metabolism. Nature Reviews Endocrinology 2018; 14(5): 259 doi: 10.1038/nrendo.2018.10
|
| 24 |
Sumedha Liyanage, Noureddine Abidi. Fourier transform infrared applications to investigate induced biochemical changes in liver. Applied Spectroscopy Reviews 2020; 55(9-10): 840 doi: 10.1080/05704928.2019.1692307
|
| 25 |
Aline Xavier, Flavia Zacconi, Constanza Gainza, Daniel Cabrera, Marco Arrese, Sergio Uribe, Carlos Sing-Long, Marcelo E. Andia. Intrahepatic fatty acids composition as a biomarker of NAFLD progression from steatosis to NASH by using1H-MRS. RSC Advances 2019; 9(72): 42132 doi: 10.1039/C9RA08914D
|
| 26 |
方行 周. The Regulation Mechanisms of Anthocyanins on Lipid Metabolism in Non-Alcoholic Fatty Liver. Hans Journal of Food and Nutrition Science 2015; 4(04): 116 doi: 10.12677/HJFNS.2015.44016
|
| 27 |
Yuneivy Cepero-Donates, Volatiana Rakotoarivelo, Marian Mayhue, Averil Ma, Yi-Guang Chen, Sheela Ramanathan. Homeostasis of IL-15 dependent lymphocyte subsets in the liver. Cytokine 2016; 82: 95 doi: 10.1016/j.cyto.2015.12.012
|
| 28 |
Haneesha Mohan, Sydney L. Brandt, Ja Hyun Kim, Frances Wong, Mi Lai, Kacey J. Prentice, Dana Al Rijjal, Lilia Magomedova, Battsetseg Batchuluun, Elena Burdett, Alpana Bhattacharjee, Carolyn L. Cummins, Denise D. Belsham, Brian Cox, Ying Liu, Michael B. Wheeler. 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid (CMPF) prevents high fat diet‐induced insulin resistance via maintenance of hepatic lipid homeostasis. Diabetes, Obesity and Metabolism 2019; 21(1): 61 doi: 10.1111/dom.13483
|
| 29 |
Idris Adewale Ahmed, Maryam Abimbola Mikail, Mohammad Rais Mustafa, Muhammad Ibrahim, Rozana Othman. Lifestyle interventions for non-alcoholic fatty liver disease. Saudi Journal of Biological Sciences 2019; 26(7): 1519 doi: 10.1016/j.sjbs.2018.12.016
|
| 30 |
Helen S. Te. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; : 1398 doi: 10.1016/B978-0-323-40232-3.00119-9
|
| 31 |
Subrata Deb, Prasanth Puthanveetil, Prashant Sakharkar. A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels. International Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/1286170
|
| 32 |
Herath Mudiyanselage Meththananda Herath, Iroshani Kodikara, Thilak Priyantha Weerarathna, Gayani Liyanage. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(1): 246 doi: 10.1016/j.dsx.2018.09.002
|
| 33 |
Rasoul Shafiezadeh, Seyed Moayed Alavian, Hasan Namdar, Mohammad Gholami-Fesharaki, Seyed Saeid Esmaeili. Evaluating the Efficacy of Carum Copticum Seeds on the Treatment of Patients with Nonalcoholic Fatty Liver Disease: A Multi-Center, Randomized, Triple–Blind, Placebo-Controlled Clinical Trial Study. Hepatitis Monthly 2021; 20(12) doi: 10.5812/hepatmon.110488
|
| 34 |
Abd Elkhalek Hamed, Nadia Elwan, Mervat Naguib, Reda Elwakil, Gamal Esmat, Mohamed El Kassas, Sherief Abd-Elsalam, Shorouk Moussa. Diabetes Association with Liver Diseases: An Overview for Clinicians. Endocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19(3): 274 doi: 10.2174/1871530318666181116111945
|
| 35 |
Andrea Gallotta, Laura Paneghetti, Viera Mrázová, Adriana Bednárová, Dáša Kružlicová, Vladimir Frecer, Stanislav Miertus, Alessandra Biasiolo, Andrea Martini, Patrizia Pontisso, Giorgio Fassina. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients. The International Journal of Biological Markers 2018; 33(2): 231 doi: 10.1177/1724600817753577
|
| 36 |
Wilson Yip, Ivana Sequeira, Lindsay Plank, Sally Poppitt. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia. Nutrients 2017; 9(11): 1273 doi: 10.3390/nu9111273
|
| 37 |
Srilekha Muthukaruppankaruppiah, Shanker Rajendiran Nagalingam, Priya Murugasen, Rajesh Nandaamarnath. Human Fatty Liver Monitoring Using Nano Sensor and IoMT. Intelligent Automation & Soft Computing 2023; 35(2): 2309 doi: 10.32604/iasc.2023.029598
|
| 38 |
Jude M. Taylor, Amy Li, Craig S. McLachlan. Immune cell profile and immune‐related gene expression of obese peripheral blood and liver tissue. FEBS Letters 2022; 596(2): 199 doi: 10.1002/1873-3468.14248
|
| 39 |
Mehrnoosh Zakerkish, Abolghasem Assarzadeh, Seyed Saeed Seyedian, Alireza Jahanshahi. Prevalence of Metabolic Syndrome and Related Factors in Patients with Non-alcoholic Fatty Liver. Jundishapur Journal of Chronic Disease Care 2021; 11(1) doi: 10.5812/jjcdc.114541
|
| 40 |
Jinfei Yang, Weiwei Yao, Huihui Yang, Yajing Shen, Yuanyuan Zhang. Design and synthesis of ERα agonists: Effectively reduce lipid accumulation. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.1104249
|
| 41 |
Gehan H. Heeba, Reham M. El-Deen, Rania G. Abdel-latif, Mohamed M.A. Khalifa. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study. Canadian Journal of Physiology and Pharmacology 2020; 98(8): 498 doi: 10.1139/cjpp-2019-0487
|
| 42 |
Hye Rim Jang, Hyun-Jun Park, Dongwon Kang, Hayung Chung, Myung Hee Nam, Yeonhee Lee, Jae-Hak Park, Hui-Young Lee. A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption. Experimental & Molecular Medicine 2019; 51(8): 1 doi: 10.1038/s12276-019-0293-4
|
| 43 |
Yu-Ying Xu, Juan Ge, Mo-Han Zhang, Wen-Jie Sun, Jun Zhang, Pei-Lin Yu, Yi-Fan Zheng, Jun Yang, Xin-Qiang Zhu. Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley Rats. International Journal of Toxicology 2016; 35(6): 634 doi: 10.1177/1091581816653363
|
| 44 |
Shamsul Mohd Zain, Hwa‐Li Tan, Zahurin Mohamed, Wah‐Kheong Chan, Sanjiv Mahadeva, Roma Choudhury Basu, Rosmawati Mohamed. Use of simple scoring systems for a public health approach in the management of non‐alcoholic fatty liver disease patients. JGH Open 2020; 4(6): 1155 doi: 10.1002/jgh3.12414
|
| 45 |
Si-Si Jin, Xian-Fan Lin, Ju-Zeng Zheng, Qiong Wang, Hua-Qin Guan. lncRNA NEAT1 regulates fibrosis and inflammatory response induced by nonalcoholic fatty liver by regulating miR-506/GLI3. European Cytokine Network 2019; 30(3): 98 doi: 10.1684/ecn.2019.0432
|
| 46 |
Dan-Qin Sun, Wen-Yue Liu, Sheng-Jie Wu, Gui-Qi Zhu, Martin Braddock, Dong-Chu Zhang, Ke-Qing Shi, Dan Song, Ming-Hua Zheng. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease. Oncotarget 2016; 7(5): 5728 doi: 10.18632/oncotarget.6799
|
| 47 |
Graziella Rodrigues, Andrea Janz Moreira, Silvia Bona, Elizângela Schemitt, Cláudio Augusto Marroni, Fábio Cangeri Di Naso, Alexandre Simões Dias, Thienne Rocha Pires, Jaqueline Nascimento Picada, Norma Possa Marroni. Simvastatin Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in Nonalcoholic Steatohepatitis Experimental Model. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/3201873
|
| 48 |
Juliana F. Miranda, Letícia D. Scarinci, Letícia F. Ramos, Caio M. Silva, Letícia R. Gonçalves, Priscila F. de Morais, Osmar Malaspina, Karen C. M. Moraes. The modulatory effect of triclosan on the reversion of the activated phenotype of LX‐2 hepatic stellate cells. Journal of Biochemical and Molecular Toxicology 2020; 34(1) doi: 10.1002/jbt.22413
|
| 49 |
Christian Lüchtenborg, Birgit Niederhaus, Britta Brügger, Branko Popovic, Gert Fricker. Lipid Profiles of Five Essential Phospholipid Preparations for the Treatment of Nonalcoholic Fatty Liver Disease: A Comparative Study. Lipids 2020; 55(3): 271 doi: 10.1002/lipd.12236
|
| 50 |
Maryam Vaezi, Parichehreh Yaghmaei, Nasim Hayati-Roodbari, Shiva Irani, Azadeh Ebrahim-Habibi. Citral effect in male NMRI mice nonalcoholic steatosis model: assessing biochemical and histological parameters and PPARα gene expression. Brazilian Journal of Pharmaceutical Sciences 2018; 54(3) doi: 10.1590/s2175-97902018000317596
|
| 51 |
Huafeng Wang, Dong Wang, Luhong Yang, Yanxia Wang, Junli Jia, Dongchen Na, Huize Chen, Yongping Luo, Chengfang Liu. Compact bone-derived mesenchymal stem cells attenuate nonalcoholic steatohepatitis in a mouse model by modulation of CD4 cells differentiation. International Immunopharmacology 2017; 42: 67 doi: 10.1016/j.intimp.2016.11.012
|
| 52 |
Yi Tang, Ze-min Wei, Ning Li, Lin-lin Sun, Zheng-yu Jin, Zhe Wu, Hao Sun. Quantitative analysis of the risk of type 2 diabetes and fatty liver in non-obese individuals by computed tomography. Abdominal Radiology 2022; 47(6): 2099 doi: 10.1007/s00261-022-03506-4
|
| 53 |
Torsten Diesinger, Alfred Lautwein, Vyacheslav Buko, Elena Belonovskaya, Oksana Lukivskaya, Elena Naruta, Siarhei Kirko, Viktor Andreev, Radovan Dvorsky, Dominik Buckert, Sebastian Bergler, Christian Renz, Dieter Müller‐Enoch, Thomas Wirth, Thomas Haehner. ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis. Physiological Reports 2021; 9(6) doi: 10.14814/phy2.14795
|
| 54 |
Laura Braud, Sylvain Battault, Grégory Meyer, Alessandro Nascimento, Sandrine Gaillard, Georges de Sousa, Roger Rahmani, Catherine Riva, Martine Armand, Jean-Michel Maixent, Cyril Reboul. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model. The Journal of Nutritional Biochemistry 2017; 40: 95 doi: 10.1016/j.jnutbio.2016.10.012
|
| 55 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
|
| 56 |
Donald A. Williamson. Prevention of type 2 diabetes: what is the right target population?. Expert Review of Endocrinology & Metabolism 2018; 13(6): 295 doi: 10.1080/17446651.2018.1535896
|
| 57 |
Wei Wang, Ai-Lei Xu, Zheng-Chao Li, Yi Li, Shun-Fu Xu, Hua-Chao Sang, Fachao Zhi. Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. Diabetes & Metabolism Journal 2020; 44(2): 336 doi: 10.4093/dmj.2019.0042
|
| 58 |
Molood Bagherieh, Asma Kheirollahi, Fahimeh Zamani-Garmsiri, Solaleh Emamgholipour, Reza Meshkani. Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells. Archives of Physiology and Biochemistry 2023; 129(4): 893 doi: 10.1080/13813455.2021.1878539
|
| 59 |
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus 2021; doi: 10.7759/cureus.17321
|
| 60 |
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences 2016; 73(10): 1969 doi: 10.1007/s00018-016-2161-x
|
| 61 |
Wim Verlinden, Eugénie Van Mieghem, Laura Depauw, Thomas Vanwolleghem, Luisa Vonghia, Jonas Weyler, Ann Driessen, Dirk Callens, Laurence Roosens, Eveline Dirinck, An Verrijken, Luc Van Gaal, Sven Francque. Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis. Biomedicines 2020; 8(12): 546 doi: 10.3390/biomedicines8120546
|
| 62 |
Jinjie Duan, Yayue Song, Xu Zhang, Chunjiong Wang. Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.646491
|
| 63 |
John D. Clarke, Anika Dzierlenga, Tarana Arman, Erica Toth, Hui Li, Katherine D. Lynch, Dan-Dan Tian, Michael Goedken, Mary F. Paine, Nathan Cherrington. Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicity. Toxicon 2019; 162: 1 doi: 10.1016/j.toxicon.2019.03.002
|
| 64 |
O. M. Drapkina, R. N. Shepel, E. P. Yakovenko, E. V. Zyatenkova. Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease. Profilakticheskaya meditsina 2019; 22(2): 82 doi: 10.17116/profmed20192202182
|
| 65 |
Victoria Sid, Yaw L. Siow, Karmin O. Role of folate in nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology 2017; 95(10): 1141 doi: 10.1139/cjpp-2016-0681
|
| 66 |
Ebenezer I. O. Ajayi, Olorunfemi R. Molehin, Omotade I. Oloyede, Vinod Kumar, Venkateswara R. Amara, Jasmine Kaur, Pinakin Karpe, Kulbhushan Tikoo. Liver mitochondrial membrane permeability modulation in insulin-resistant, uninephrectomised male rats by Clerodendrum volubile P. Beauv and Manihot esculenta Crantz. Clinical Phytoscience 2019; 5(1) doi: 10.1186/s40816-019-0124-0
|
| 67 |
Mingzhe Zhu, Shijun Hao, Tao Liu, Lili Yang, Peiyong Zheng, Li Zhang, Guang Ji. Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq. Oncotarget 2017; 8(47): 82621 doi: 10.18632/oncotarget.19734
|
| 68 |
Gina Coudriet, Meghan Delmastro-Greenwood, Dana Previte, Meghan Marré, Erin O’Connor, Elizabeth Novak, Garret Vincent, Kevin Mollen, Sojin Lee, H. Dong, Jon Piganelli. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. Antioxidants 2017; 6(4): 85 doi: 10.3390/antiox6040085
|
| 69 |
Jan Rozman, Birgit Rathkolb, Manuela A. Oestereicher, Christine Schütt, Aakash Chavan Ravindranath, Stefanie Leuchtenberger, Sapna Sharma, Martin Kistler, Monja Willershäuser, Robert Brommage, Terrence F. Meehan, Jeremy Mason, Hamed Haselimashhadi, Antonio Aguilar-Pimentel, Lore Becker, Irina Treise, Kristin Moreth, Lillian Garrett, Sabine M. Hölter, Annemarie Zimprich, Susan Marschall, Oana V. Amarie, Julia Calzada-Wack, Frauke Neff, Laura Brachthäuser, Christoph Lengger, Claudia Stoeger, Lilly Zapf, Yi-Li Cho, Patricia da Silva-Buttkus, Markus J. Kraiger, Philipp Mayer-Kuckuk, Karen Kristine Gampe, Moya Wu, Nathalie Conte, Jonathan Warren, Chao-Kung Chen, Ilinca Tudose, Mike Relac, Peter Matthews, Heather L. Cater, Helen P. Natukunda, James Cleak, Lydia M. Teboul, Sharon Clementson-Mobbs, Zsombor Szoke-Kovacs, Alison P. Walling, Sara J. Johnson, Gemma F. Codner, Tanja Fiegel, Natalie Ring, Henrik Westerberg, Simon Greenaway, Duncan Sneddon, Hugh Morgan, Jorik Loeffler, Michelle E. Stewart, Ramiro Ramirez-Solis, Allan Bradley, William C. Skarnes, Karen P. Steel, Simon A. Maguire, Joshua Dench, David Lafont, Valerie E. Vancollie, Selina A. Pearson, Amy S. Gates, Mark Sanderson, Carl Shannon, Lauren F. E. Anthony, Maksymilian T. Sumowski, Robbie S. B. McLaren, Brendan Doe, Hannah Wardle-Jones, Mark N. D. Griffiths, Antonella Galli, Agnieszka Swiatkowska, Christopher M. Isherwood, Anneliese O. Speak, Emma L. Cambridge, Heather M. Wilson, Susana S. Caetano, Anna Karin B. Maguire, David J. Adams, Joanna Bottomley, Ed Ryder, Diane Gleeson, Laurent Pouilly, Stephane Rousseau, Aurélie Auburtin, Patrick Reilly, Abdel Ayadi, Mohammed Selloum, Joshua A. Wood, Dave Clary, Peter Havel, Todd Tolentino, Heather Tolentino, Mike Schuchbauer, Sheryl Pedroia, Amanda Trainor, Esi Djan, Milton Pham, Alison Huynh, Vincent De Vera, John Seavitt, Juan Gallegos, Arturo Garza, Elise Mangin, Joel Senderstrom, Iride Lazo, Kate Mowrey, Ritu Bohat, Rodney Samaco, Surabi Veeraragavan, Christine Beeton, Sowmya Kalaga, Lois Kelsey, Igor Vukobradovic, Zorana Berberovic, Celeste Owen, Dawei Qu, Ruolin Guo, Susan Newbigging, Lily Morikawa, Napoleon Law, Xueyuan Shang, Patricia Feugas, Yanchun Wang, Mohammad Eskandarian, Yingchun Zhu, Patricia Penton, Valerie Laurin, Shannon Clarke, Qing Lan, Gillian Sleep, Amie Creighton, Elsa Jacob, Ozge Danisment, Marina Gertsenstein, Monica Pereira, Suzanne MacMaster, Sandra Tondat, Tracy Carroll, Jorge Cabezas, Jane Hunter, Greg Clark, Mohammed Bubshait, David Miller, Khondoker Sohel, Hibret Adissu, Milan Ganguly, Alexandr Bezginov, Francesco Chiani, Chiara Di Pietro, Gianfranco Di Segni, Olga Ermakova, Filomena Ferrara, Paolo Fruscoloni, Aalessia Gambadoro, Serena Gastaldi, Elisabetta Golini, Gina La Sala, Silvia Mandillo, Daniela Marazziti, Marzia Massimi, Rafaele Matteoni, Tiziana Orsini, Miriam Pasquini, Marcello Raspa, Aline Rauch, Gianfranco Rossi, Nicoletta Rossi, Sabrina Putti, Ferdinando Scavizzi, Giuseppe D. Tocchini-Valentini, Shigeharu Wakana, Tomohiro Suzuki, Masaru Tamura, Hideki Kaneda, Tamio Furuse, Kimio Kobayashi, Ikuo Miura, Ikuko Yamada, Yuichi Obata, Atsushi Yoshiki, Shinya Ayabe, J. Nicole Chambers, Karel Chalupsky, Claudia Seisenberger, Antje Bürger, Joachim Beig, Ralf Kühn, Andreas Hörlein, Joel Schick, Oskar Oritz, Florian Giesert, Jochen Graw, Markus Ollert, Carsten Schmidt-Weber, Tobias Stoeger, Ali Önder Yildirim, Oliver Eickelberg, Thomas Klopstock, Dirk H. Busch, Raffi Bekeredjian, Andreas Zimmer, Jules O. Jacobsen, Damian Smedley, Mary E. Dickinson, Frank Benso, Iva Morse, Hyoung-Chin Kim, Ho Lee, Soo Young Cho, Tertius Hough, Ann-Marie Mallon, Sara Wells, Luis Santos, Christopher J. Lelliott, Jacqueline K. White, Tania Sorg, Marie-France Champy, Lynette R. Bower, Corey L. Reynolds, Ann M. Flenniken, Stephen A. Murray, Lauryl M. J. Nutter, Karen L. Svenson, David West, Glauco P. Tocchini-Valentini, Arthur L. Beaudet, Fatima Bosch, Robert B. Braun, Michael S. Dobbie, Xiang Gao, Yann Herault, Ala Moshiri, Bret A. Moore, K. C. Kent Lloyd, Colin McKerlie, Hiroshi Masuya, Nobuhiko Tanaka, Paul Flicek, Helen E. Parkinson, Radislav Sedlacek, Je Kyung Seong, Chi-Kuang Leo Wang, Mark Moore, Steve D. Brown, Matthias H. Tschöp, Wolfgang Wurst, Martin Klingenspor, Eckhard Wolf, Johannes Beckers, Fausto Machicao, Andreas Peter, Harald Staiger, Hans-Ulrich Häring, Harald Grallert, Monica Campillos, Holger Maier, Helmut Fuchs, Valerie Gailus-Durner, Thomas Werner, Martin Hrabe de Angelis. Identification of genetic elements in metabolism by high-throughput mouse phenotyping. Nature Communications 2018; 9(1) doi: 10.1038/s41467-017-01995-2
|
| 70 |
Type 3 diabetes with links to NAFLD and Other Chronic Diseases in the Western World. International Journal of Diabetes & Metabolic Disorders 2016; 1(1) doi: 10.33140/IJDMD/00007
|
| 71 |
Hamda M. Aboujassoum, Vidya Mohamed-Ali, David Abraham, Lucie H. Clapp, Hamda A. Al-Naemi. Relative Recovery of Non-Alcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Rats. Nutrients 2023; 16(1): 115 doi: 10.3390/nu16010115
|
| 72 |
Islam N. Mohamed, Nahla Reda Sarhan, Mohamed Ahmed Eladl, Azza B. El-Remessy, Mohamed El-Sherbiny. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study. Acta Histochemica 2018; 120(3): 242 doi: 10.1016/j.acthis.2018.02.006
|
| 73 |
Vanessa Souza-Mello. Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. World Journal of Hepatology 2017; 9(2): 74-79 doi: 10.4254/wjh.v9.i2.74
|
| 74 |
Jadwiga Konieczna, Miguel Fiol, Antoni Colom, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Dolores Corella, María Trinidad Soria-Florido, J. Alfredo Martínez, Ángel M. Alonso-Gómez, Julia Wärnberg, Jesús Vioque, José López-Miranda, Ramon Estruch, M. Rosa Bernal-López, José Lapetra, Lluís Serra-Majem, Aurora Bueno-Cavanillas, Josep A. Tur, Vicente Martín Sánchez, Xavier Pintó, José J. Gaforio, Pilar Matía-Martín, Josep Vidal, Clotilde Vázquez, Lidia Daimiel, Emilio Ros, Maira Bes-Rastrollo, María Pascual, Jose V. Sorlí, Albert Goday, María Ángeles Zulet, Anai Moreno-Rodriguez, Francisco Jesús Carmona González, Rafael Valls-Enguix, Juana M. Janer, Antonio Garcia-Rios, Rosa Casas, Ana M. Gomez-Perez, José Manuel Santos-Lozano, F. Javier Basterra-Gortari, María Ángeles Martínez, Carolina Ortega-Azorin, Joan Bayó, Itziar Abete, Itziar Salaverria-Lete, Miguel Ruiz-Canela, Nancy Babio, Lourdes Carres, Dora Romaguera. Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome. Nutrients 2022; 14(19): 4142 doi: 10.3390/nu14194142
|
| 75 |
Maryam Ghadimi, Roya Rezvani Habibabadi, Bita Hazhirkarzar, Mohammadreza Shaghaghi, Sanaz Ameli, Pegah Khoshpouri, Mounes Aliyari Ghasabeh, Ahmet Gurakar, Timothy M. Pawlik, Ihab R. Kamel. Advances in Imaging of Diffuse Parenchymal Liver Disease. Journal of Clinical Gastroenterology 2020; 54(8): 682 doi: 10.1097/MCG.0000000000001380
|
| 76 |
Yuanping Shi, Sin Man Lam, Hong Liu, Guanghua Luo, Jun Zhang, Shuang Yao, Jie Li, Lu Zheng, Ning Xu, Xiaoying Zhang, Guanghou Shui. Comprehensive lipidomics in apoM mice reveals an overall state of metabolic distress and attenuated hepatic lipid secretion into the circulation. Journal of Genetics and Genomics 2020; 47(9): 523 doi: 10.1016/j.jgg.2020.08.003
|
| 77 |
Yi Du, Dejun Su, Kendra L. Ratnapradipa, Jianghu Dong, Fedja A. Rochling, Paraskevi A. Farazi. Factors Associated with Awareness and Knowledge of Nonalcoholic Fatty Liver Disease, a Liver Cancer Etiological Factor, Among Chinese Young Adults. Journal of Cancer Education 2023; 38(4): 1177 doi: 10.1007/s13187-022-02246-9
|
| 78 |
Alireza Rahmanabadi, Soltanali Mahboob, Farshad Amirkhizi, Sonya Hosseinpour-Arjmand, Mehrangiz Ebrahimi-Mameghani. Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features. Food & Function 2019; 10(8): 4941 doi: 10.1039/C9FO00449A
|
| 79 |
Rahanuma Raihanu Kathak, Abu Hasan Sumon, Noyan Hossain Molla, Mahmudul Hasan, Rakib Miah, Humaira Rashid Tuba, Ahsan Habib, Nurshad Ali. The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-05766-y
|
| 80 |
Cong Liu, Jia-Zhi Liao, Pei-Yuan Li. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(11): 1964-1973 doi: 10.3748/wjg.v23.i11.1964
|
| 81 |
V. I. Prymachenko. Changes in the Structure of the Liver during Obesity (Literature Review). Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2018; 4(2): 45 doi: 10.26693/jmbs04.02.045
|
| 82 |
Aline Xavier, Flavia Zacconi, Daniel Cabrera, Karen Fuenzalida, Marcelo Andia. XXVI Brazilian Congress on Biomedical Engineering. IFMBE Proceedings 2019; : 51 doi: 10.1007/978-981-13-2119-1_8
|
| 83 |
Karen Jackson, Noa Dressler, Rotem S Ben-Shushan, Ari Meerson, Tyler W LeBaron, Snait Tamir. Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model. World Journal of Gastroenterology 2018; 24(45): 5095-5108 doi: 10.3748/wjg.v24.i45.5095
|
| 84 |
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease association. Arab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
|
| 85 |
Abeer M. ElDeeb, Hany F. Elsisi, Yasser R. Lasheen. Response of lipids, estradiol level, and liver size to diet and high-intensity interval training in postmenopausal women with fatty liver. Bulletin of Faculty of Physical Therapy 2018; 23(2): 69 doi: 10.4103/bfpt.bfpt_6_18
|
| 86 |
Ann Margaret C. Navarroza, Stephen N. Wong. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease. Indian Journal of Gastroenterology 2021; 40(4): 380 doi: 10.1007/s12664-021-01184-6
|
| 87 |
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>®</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?. World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
|
| 88 |
David Fernández-Ramos, Fernando Lopitz-Otsoa, Laura Delacruz-Villar, Jon Bilbao, Martina Pagano, Laura Mosca, Maider Bizkarguenaga, Marina Serrano-Macia, Mikel Azkargorta, Marta Iruarrizaga-Lejarreta, Jesús Sot, Darya Tsvirkun, Sebastiaan Martijn van Liempd, Felix M Goni, Cristina Alonso, María Luz Martínez-Chantar, Felix Elortza, Liat Hayardeny, Shelly C Lu, José M Mato. Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis <i>via</i> AMPK and mTOR regulation. World Journal of Gastroenterology 2020; 26(34): 5101-5117 doi: 10.3748/wjg.v26.i34.5101
|
| 89 |
Maria Stepanova, Linda Henry, Zobair M. Younossi. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2023; 27(2): 483 doi: 10.1016/j.cld.2023.01.007
|
| 90 |
Xiankuan Li, Weisan Chen, Jiali Ren, Xinchen Gao, Ying Zhao, Tianbao Song, Kun Fu, Yanchao Zheng, Jinlong Yang. Effects of curcumin on non-alcoholic fatty liver disease: A scientific metrogy study. Phytomedicine 2024; 123: 155241 doi: 10.1016/j.phymed.2023.155241
|
| 91 |
Nicholas J. G. Webster. Alternative RNA Splicing in the Pathogenesis of Liver Disease. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00133
|
| 92 |
Fatemeh Kalaki-Jouybari, Mehrnoosh Shanaki, Maryam Delfan, Sattar Gorgani-Firouzjae, Soheyla Khakdan. High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. Archives of Physiology and Biochemistry 2020; 126(3): 242 doi: 10.1080/13813455.2018.1510968
|
| 93 |
Weaam Gouda, Esmat Ashour, Yehia Shaker, Wafaa Ezzat. MTP genetic variants associated with non-alcoholic fatty liver in metabolic syndrome patients. Genes & Diseases 2017; 4(4): 222 doi: 10.1016/j.gendis.2017.09.002
|
| 94 |
Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats. Nutrients 2019; 11(5): 961 doi: 10.3390/nu11050961
|
| 95 |
Katherine A. Pratte, Ann Johnson, Janette Beals, Ann Bullock, Spero M. Manson, Luohua Jiang. Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program. Diabetes Care 2019; 42(7): 1209 doi: 10.2337/dc18-1964
|
| 96 |
Martin L. Decaris, Kelvin W. Li, Claire L. Emson, Michelle Gatmaitan, Shanshan Liu, Yenny Wang, Edna Nyangau, Marc Colangelo, Thomas E. Angel, Carine Beysen, Jeffrey Cui, Carolyn Hernandez, Len Lazaro, David A. Brenner, Scott M. Turner, Marc K. Hellerstein, Rohit Loomba. Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood. Hepatology 2017; 65(1): 78 doi: 10.1002/hep.28860
|
| 97 |
Saioa Gómez-Zorita, Iñaki Milton-Laskíbar, Leixuri Aguirre, Alfredo Fernández-Quintela, Jianbo Xiao, María P. Portillo. Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids. Current Medicinal Chemistry 2020; 28(2): 238 doi: 10.2174/0929867326666191029112626
|
| 98 |
Wayne Eskridge, Donna R. Cryer, Jörn M. Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M. Allen, Mazen Noureddin, Arun J. Sanyal. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. Journal of Clinical Medicine 2023; 12(19): 6216 doi: 10.3390/jcm12196216
|
| 99 |
Maddalena Parafati, R. Jason Kirby, Sepideh Khorasanizadeh, Fraydoon Rastinejad, Siobhan Malany. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis. Disease Models & Mechanisms 2018; 11(9) doi: 10.1242/dmm.033530
|
| 100 |
Natalia Pydyn, Katarzyna Miękus, Jolanta Jura, Jerzy Kotlinowski. New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis. Pharmacological Reports 2020; 72(1): 1 doi: 10.1007/s43440-019-00020-1
|
| 101 |
Helle Sedighi Frandsen, Joel Mario Vej-Nielsen, Lauren Elizabeth Smith, Lang Sun, Karoline Lindgaard Mikkelsen, Annemette Præstegaard Thulesen, Christina Erika Hagensen, Fuquan Yang, Adelina Rogowska-Wrzesinska. Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids. Cells 2022; 11(20): 3216 doi: 10.3390/cells11203216
|
| 102 |
Deepak Kumar, Manasi Das, Consuelo Sauceda, Lesley G. Ellies, Karina Kuo, Purva Parwal, Mehak Kaur, Lily Jih, Gautam K. Bandyopadhyay, Douglas Burton, Rohit Loomba, Olivia Osborn, Nicholas J.G. Webster. Degradation of splicing factor SRSF3 contributes to progressive liver disease. Journal of Clinical Investigation 2019; 129(10): 4477 doi: 10.1172/JCI127374
|
| 103 |
Mohammad Hassan Baig, Preeti Gupta, Mohd. Imran Khan, Mohamed F. Alajmi, Afzal Hussain, Md. Imtaiyaz Hassan, Jae-June Dong. Probing the Interaction of Selonsertib with Human Serum Albumin: In
silico and In vitro Approaches. Current Topics in Medicinal Chemistry 2022; 22(10): 879 doi: 10.2174/1568026622666220330012032
|
| 104 |
Shima Dowla, Stella Aslibekyan, Amy Goss, Kevin Fontaine, Ambika P. Ashraf. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease. Journal of Clinical Lipidology 2018; 12(4): 981 doi: 10.1016/j.jacl.2018.03.089
|
| 105 |
Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, Andy Lin, Lai Wei, Anna S. Lok. Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. Digestive Diseases and Sciences 2019; 64(12): 3480 doi: 10.1007/s10620-019-05709-0
|
| 106 |
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
|
| 107 |
Il-Sup Kim. Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans. Antioxidants 2021; 10(7): 1064 doi: 10.3390/antiox10071064
|
| 108 |
Hao Han, Fubin Qiu, Haifeng Zhao, Haiying Tang, Xiuhua Li, Dongxing Shi. Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice. Oxidative Medicine and Cellular Longevity 2017; 2017: 1 doi: 10.1155/2017/3256241
|
| 109 |
Suhad Bahijri, Basmah Eldakhakhny, Sumia Enani, Ghada Ajabnoor, Alaa S Al-Mowallad, Lubna Alsheikh, Amani Alhozali, Aliaa A Alamoudi, Anwar Borai, Jaakko Tuomilehto. Fibroblast Growth Factor 21: A More Effective Biomarker Than Free Fatty Acids and Other Insulin Sensitivity Measures for Predicting Non-alcoholic Fatty Liver Disease in Saudi Arabian Type 2 Diabetes Patients. Cureus 2023; doi: 10.7759/cureus.50524
|
| 110 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|
| 111 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
|
| 112 |
Zahra Namkhah, Fatemeh Naeini, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh‐Attar. The association of the adipokine zinc‐alpha2‐glycoprotein with non‐alcoholic fatty liver disease and related risk factors: A comprehensive systematic review. International Journal of Clinical Practice 2021; 75(7) doi: 10.1111/ijcp.13985
|
| 113 |
Alfredo Fernández-Quintela, Marcela González, Leixuri Aguirre, Iñaki Milton-Laskibar, Asier Léniz, Maria P. Portillo. The Liver. 2018; : 199 doi: 10.1016/B978-0-12-803951-9.00017-3
|
| 114 |
Xiao Li, Virgia Wang. Genetic evidence for the causal relationship between NAFLD and brain functional connectivity. 2022 6th International Conference on Biomedical Engineering and Applications (ICBEA) 2022; : 77 doi: 10.1145/3543081.3543093
|
| 115 |
Amir Mari, Sohaib Omari, Fadi Abu Baker, Saif Abu Much, Helal Said Ahmad, Tawfik Khoury, William Nseir, Mahmud Mahamid. Non-alcoholic fatty liver disease: a survey of involvement of primary care physicians. Minerva Gastroenterologica e Dietologica 2020; 65(4) doi: 10.23736/S1121-421X.19.02618-7
|
| 116 |
Woo Jin Choi, Hye Jin Dong, Hyun Uk Jeong, Dong Wook Ryu, Soo Min Song, Yu Ri Kim, Hyun Ho Jung, Tai Hoon Kim, Yeung-Hyen Kim. Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57615-5
|
| 117 |
Siouar Bensaid, Amar Kachenoura, Nathalie Costet, Victor De Ledinghen, Julien Vergniol, Fabrice Laine, Bruno Turlin, Hugues Tariel, Lotfi Senhadji. Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy. 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2016; : 3602 doi: 10.1109/EMBC.2016.7591507
|
| 118 |
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang, Weida Tong. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH. Biomarkers in Medicine 2015; 9(11): 1189 doi: 10.2217/bmm.15.70
|
| 119 |
Nima Motamed, Behnam Rabiee, Hossein Poustchi, Babak Dehestani, Gholam Reza Hemasi, Mahmood Reza Khonsari, Mansooreh Maadi, Fatemeh Sima Saeedian, Farhad Zamani. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. Clinics and Research in Hepatology and Gastroenterology 2017; 41(1): 31 doi: 10.1016/j.clinre.2016.07.005
|
| 120 |
Yongeun Kim, Sathish Kumar Natarajan, Soonkyu Chung. Gamma‐Tocotrienol Attenuates the Hepatic Inflammation and Fibrosis by Suppressing Endoplasmic Reticulum Stress in Mice. Molecular Nutrition & Food Research 2018; 62(21) doi: 10.1002/mnfr.201800519
|
| 121 |
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2018; 19(7): 2034 doi: 10.3390/ijms19072034
|
| 122 |
Jialiu Zeng, Rebeca Acin-Perez, Essam A. Assali, Andrew Martin, Alexandra J. Brownstein, Anton Petcherski, Lucía Fernández-del-Rio, Ruiqing Xiao, Chih Hung Lo, Michaël Shum, Marc Liesa, Xue Han, Orian S. Shirihai, Mark W. Grinstaff. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-38165-6
|
| 123 |
Wenli Liu, Chenji Ye, Qian Cheng, Xuejiao Zhang, Liu Yao, Qi Li, Jing Huang, Yajin Liu, Zhengsheng Zou, Hua Wang, Jun Yan, Yi Zhu, Chunjiong Wang, Ding Ai. Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis. Cellular and Molecular Gastroenterology and Hepatology 2019; 7(1): 211 doi: 10.1016/j.jcmgh.2018.09.011
|
| 124 |
Jamela Jouda, Iyden Kamil Mohammed, Shatha Salah Asad, Yusur Falah Faraj, Khalid M. Salih. Effect of alteration in nutritional style on liver function tests and general stool examination. 2ND INTERNATIONAL CONFERENCE ON MATERIALS ENGINEERING & SCIENCE (IConMEAS 2019) 2020; 2213: 020085 doi: 10.1063/5.0000232
|
| 125 |
Charlotte Brøns, Louise Groth Grunnet. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?. European Journal of Endocrinology 2017; 176(2): R67 doi: 10.1530/EJE-16-0488
|
| 126 |
Huafeng Wang, Huan Zhang, Biao Huang, Guolin Miao, Xiaoyan Yan, Gang Gao, Yongping Luo, Huize Chen, Wei Chen, Luhong Yang. Mesenchymal stem cells reverse high‑fat diet‑induced non‑alcoholic fatty liver disease through suppression of CD4+ T lymphocytes in mice. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8326
|
| 127 |
Yuhei Aotani, Yuta Kumagai, Masanobu Kameda, Kenji Wada, Toshiyuki Matsunaka, Hiroyasu Morikawa, Hiromichi Horinaka. Improvement of a combined ultrasonic probe used in ultrasonic velocity-change method for evaluation of fat content. Japanese Journal of Applied Physics 2018; 57(7S1): 07LF18 doi: 10.7567/JJAP.57.07LF18
|
| 128 |
Ali Canbay, Nandita Kachru, Jennifer Scarlet Haas, Jan‐Peter Sowa, Dominic Meise, Ahmet Burak Ozbay. Patterns and predictors of mortality and disease progression among patients with non‐alcoholic fatty liver disease . Alimentary Pharmacology & Therapeutics 2020; 52(7): 1185 doi: 10.1111/apt.16016
|
| 129 |
Wei Zhang, Samantha Chao, Stephanie Chen, Huiying Rao, Rui Huang, Lai Wei, Anna S. Lok. Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China. Digestive Diseases and Sciences 2019; 64(3): 708 doi: 10.1007/s10620-018-5389-5
|
| 130 |
Laura S. Chiu, Alison Pedley, Joseph M. Massaro, Emelia J. Benjamin, Gary F. Mitchell, David D. McManus, Jayashri Aragam, Ramachandran S. Vasan, Susan Cheng, Michelle T. Long. The association of non‐alcoholic fatty liver disease and cardiac structure and function—Framingham Heart Study. Liver International 2020; 40(10): 2445 doi: 10.1111/liv.14600
|
| 131 |
Ghada M. A. Ajabnoor, Suhad M. Bahijri, Sumia Mohammad Enani, Lubna Alsheikh, Maimoona Ahmed, Amani Alhozali, Khalid Al-Shali, Basmah Medhat Eldakhakhny, Aliaa A. Alamoudi, Jawaher Al-Ahmadi, Anwar Borai, Alaa Salem Al-Mowallad, Jaakko Tuomilehto. Exploring the Validity of Available Markers and Indices in the Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) in People with Type 2 Diabetes in Saudi Arabia. Diseases 2023; 11(1): 10 doi: 10.3390/diseases11010010
|
| 132 |
Hongzeng Li, Wen Yuan, Yuxin Tian, Feiyue Tian, Yunfei Wang, Xiangrong Sun, Yanling Gong. Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1. Archives of Biochemistry and Biophysics 2022; 725: 109269 doi: 10.1016/j.abb.2022.109269
|
| 133 |
Sutapa Sarkar, Diana Kimono, Muayad Albadrani, Ratanesh K. Seth, Philip Busbee, Hasan Alghetaa, Dwayne E. Porter, Geoff I. Scott, Bryan Brooks, Mitzi Nagarkatti, Prakash Nagarkatti, Saurabh Chatterjee. Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45009-1
|
| 134 |
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. Pharmaceuticals 2020; 13(9): 222 doi: 10.3390/ph13090222
|
| 135 |
Mahmud Mahamid, Omar Abu-Elhija, Tarik Yassin, William Nseir. Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/2054871
|
| 136 |
Hsun-Chin Chao, Hsin-Yeh Lin. Comparison of Body Mass Index and Fat Indices in Predicting the Severity of Nonalcoholic Fatty Liver Disease Among Children Who Are Overweight and Obese. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.724426
|
| 137 |
Yadi Li, Yan Yang, Yufang Li, Ping Zhang, Gaiying Ge, Jing Jin, Ting Du, Maiyan Ma, Li Na, Lu Ding, Huiping Sheng. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. Journal of International Medical Research 2021; 49(11): 030006052110553 doi: 10.1177/03000605211055378
|
| 138 |
Brenda de Oliveira da Silva, Luciane Carla Alberici, Letícia Ferreira Ramos, Caio Mateus Silva, Marina Bonfogo da Silveira, Carlos R.P. Dechant, Scott L. Friedman, Kumiko Koibuchi Sakane, Letícia Rocha Gonçalves, Karen C.M. Moraes. Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1–7) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism. The International Journal of Biochemistry & Cell Biology 2018; 98: 137 doi: 10.1016/j.biocel.2018.02.018
|
| 139 |
Li Xue, Juntao He, Ning Gao, Xiaolan Lu, Ming Li, Xiaokang Wu, Zeshi Liu, Yaofeng Jin, Jiali Liu, Jiru Xu, Yan Geng. Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Scientific Reports 2017; 7(1) doi: 10.1038/srep45176
|
| 140 |
Nairita Roy, Frances Alencastro, Bayley A. Roseman, Sierra R. Wilson, Evan R. Delgado, Meredith C. May, Bharat Bhushan, Fiona M. Bello, Michael J. Jurczak, Sruti Shiva, Joseph Locker, Sebastien Gingras, Andrew W. Duncan. Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice. The American Journal of Pathology 2022; 192(9): 1259 doi: 10.1016/j.ajpath.2022.06.002
|